Obama Proposes $1 Billion Increase for NIH in 2016 February 06, 2015Vol.41 No.05By Matthew Bin Han Ong
Conversation with The Cancer Letter Conti: Don’t Count on an 80% Price Drop From the Launch of Neupogen’s Biosimilar February 06, 2015Vol.41 No.05By Matthew Bin Han Ong
As Biosimilar GCSF Looms Over U.S. Market, Big Players Line Up for Emerging Competition February 06, 2015Vol.41 No.05By Matthew Bin Han Ong
Desequestration? Obama, Congress Seek to Restore Federal Funding January 30, 2015Vol.41 No.04By Matthew Bin Han Ong
Duke Trial Delayed, But University to Turn Over More Documents January 30, 2015Vol.41 No.04By Paul Goldberg
Draft Bill Seeks to Revamp FDA, NIH, CMS To Accommodate 21st Century Science January 30, 2015Vol.41 No.04By Paul Goldberg
Free SWOG Chair Blanke to Climb Mt. Kilimanjaro To Focus Attention on Clinical Trial Funding January 30, 2015Vol.41 No.04By Charles D. Blanke
FreeLetter To The Editor Is $100M in Stock Enough to Make MD Anderson Go Public with its Conflict-of-Interest Management Plan? January 23, 2015Vol.41 No.03By Leonard Zwelling
